Comparative Study of the Immunogenicity of MMR (Measles, Mumps and Rubella) Single Dose and Multidose Presentations
NCT01777529
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
240
Enrollment
OTHER
Sponsor class
Conditions
Measles
Mumps
Rubella
Interventions
BIOLOGICAL:
MMR Vaccine
Sponsor
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)